A detailed history of Gamma Investing LLC transactions in Liquidia Corp stock. As of the latest transaction made, Gamma Investing LLC holds 456 shares of LQDA stock, worth $4,856. This represents 0.0% of its overall portfolio holdings.

Number of Shares
456
Previous 59 672.88%
Holding current value
$4,856
Previous $708,000 544.07%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$8.9 - $14.11 $3,533 - $5,601
397 Added 672.88%
456 $4.56 Million
Q2 2024

Jul 02, 2024

SELL
$11.96 - $15.71 $131 - $172
-11 Reduced 15.71%
59 $708,000
Q1 2024

Apr 05, 2024

BUY
$11.35 - $16.73 $794 - $1,171
70 New
70 $1.03 Million

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $685M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Gamma Investing LLC Portfolio

Follow Gamma Investing LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamma Investing LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gamma Investing LLC with notifications on news.